1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1 169 in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Vogelzang, N.; Sartor, O.; Armour, A.; Groaning, M.; Robarts, A.; Petrylak, D. P.; Tolcher, A. W.; Gordon, M. S.; Babiker, H. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
    Meeting Abstract

    Martin, M.; Loibl, S.; Hyslop, T.; de la Haba-Rodriguez, J.; Aktas, B.; Cirrincione, C.; Carrasco, E. M.; Mehta, K.; Barry, W. T.; Morales, S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • What are the health care costs for chronic lymphocytic leukemia?
    Meeting Abstract

    Matasar, M. J.; Byfield, S. D.; Blauer-Peterson, C.; Montez, M.; Reyes, C.; Masaquel, A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Cerebrospinal fluid circulating tumor cells (CSF CTC) for real-time patient monitoring and response to treatment
    Meeting Abstract

    Malani, R.; Fleisher, M.; Lin, X.; Omuro, A. M. P.; Groves, M. D.; Lin, N. U.; Melisko, M. E.; Lassrnan, A. B.; Jeyapalan, S. A.; Briggs, S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of abiraterone acetate (AA) without prednisone in castration resistant prostate cancer (CRPC)
    Meeting Abstract

    McKay, R. R.; Werner, L.; Jones, A.; Choudhury, A. D.; Pomerantz, M.; Sweeney, C.; Bubley, G. J.; Slovin, S. F.; Morris, M. J.; Kantoff, P. W.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Creating simple solutions for safe naloxone use
    Meeting Abstract

    Meadows, J.; McGee, K.; Goldberg, J.; Stabler, S. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Multicenter, randomized phase II trial of physical activity (PA), metformin (Met), or the combination on metabolic biomarkers in stage I-III colorectal (CRC) and breast cancer (BC) survivors
    Meeting Abstract

    Meyerhardt, J. A.; Irwin, M. L.; Jones, L.; Zhang, S.; Campbell, N.; Brown, J. C.; Pollak, M. N.; Sorrentino, A.; Cartmel, B.; Harrigan, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma
    Meeting Abstract

    Makker, V.; Rasco, D. W.; Dutcus, C. E.; Stepan, D. E.; Li, D.; Schmidt, E. V.; Shumaker, R. C.; Taylor, M. H.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Yu, K. H.; Cercek, A.; Hollywood, E.; Salehi, E.; Margona, E.; Bradley, M.; Witter, T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Open label, non-randomized, multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1 (c259)t in HLA-A2(+) patients with synovial sarcoma (NCT01343043)
    Meeting Abstract

    Mackall, C.; Tap, W. D.; Glod, J.; Druta, M.; Chow, W. A.; Araujo, D. M.; Grupp, S. A.; Van Tine, B. A.; Chagin, K.; Van Winkle, E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save